Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DENDREON CORP | 1,071,125 | reported | 03 Jul 2014 | tx 18+2,976,457−158,912 |
| Xeris Biopharma Holdings, Inc. | 698,083 | reported | 19 Dec 2025 | tx 25+2,241,239−458,500 |
| Applied Therapeutics, Inc. | 500,000 | reported | 19 Dec 2024 | tx 2+1,500,000 |
| SAVIENT PHARMACEUTICALS INC | 252,350 | reported | 03 Jan 2012 | tx 11+504,000−517,650 |
| AVEO PHARMACEUTICALS INC | 100,000 | reported | 01 Feb 2018 | tx 1+100,000 |
| Verastem, Inc. | 52,666 | reported | 21 May 2026 | tx 16+351,317−8,549 |
| CEMPRA, INC. | 37,400 | reported | 27 Jun 2019 | tx 15+784,100−63,000 |
| Ocugen, Inc. | 25,000 | reported | 15 Jun 2018 | tx 4+70,475 |
| TRANZYME INC | 21,044 | reported | 07 Aug 2012 | tx 2+71,044 |
| PORTOLA PHARMACEUTICALS INC | 0 | reported | 02 Jul 2020 | tx 16+86,843−86,843 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Verastem, Inc. | 36,000 | 0.00 USD | |
| 07 May 2026 | EXERCISE | Axogen, Inc. | 11,050 | 7.04 USD | |
| 07 May 2026 | SALE | Axogen, Inc. | 11,050 | 43.26 USD | |
| 07 May 2026 | EXERCISE | Axogen, Inc. | 11,050 | 0.00 USD | deriv |
| 19 Dec 2025 | SALE | Xeris Biopharma Holdings, Inc. | 135,400 | 7.22 USD | |
| 09 Dec 2025 | SALE | Axogen, Inc. | 8,545 | 29.98 USD | |
| 09 Dec 2025 | EXERCISE | Axogen, Inc. | 8,545 | 6.30 USD | |
| 08 Dec 2025 | SALE | Axogen, Inc. | 11,891 | 31.22 USD | |
| 08 Dec 2025 | EXERCISE | Axogen, Inc. | 11,891 | 6.30 USD | |
| 09 Dec 2025 | SALE | Axogen, Inc. | 13,141 | 29.98 USD | |
| 08 Dec 2025 | SALE | Axogen, Inc. | 11,802 | 31.26 USD | |
| 08 Dec 2025 | EXERCISE | Axogen, Inc. | 11,891 | 0.00 USD | deriv |
| 09 Dec 2025 | EXERCISE | Axogen, Inc. | 8,545 | 0.00 USD | deriv |
| 13 Aug 2025 | SALE | Xeris Biopharma Holdings, Inc. | 107,500 | 7.32 USD | |
| 19 Jun 2025 | GRANT_AWARD | Axogen, Inc. | 14,150 | 0.00 USD | deriv |
| 09 Jun 2025 | SALE | Axogen, Inc. | 4,073 | 10.61 USD | |
| 04 Jun 2025 | GRANT_AWARD | Xeris Biopharma Holdings, Inc. | 50,000 | 0.00 USD | |
| 22 May 2025 | GRANT_AWARD | Verastem, Inc. | 8,333 | 0.00 USD | |
| 22 May 2025 | GRANT_AWARD | Verastem, Inc. | 12,500 | 0.00 USD | deriv |
| 19 Dec 2024 | GRANT_AWARD | Applied Therapeutics, Inc. | 500,000 | 0.00 USD | |
| 19 Dec 2024 | GRANT_AWARD | Applied Therapeutics, Inc. | 1,000,000 | 0.00 USD | deriv |
| 01 Sept 2024 | EXERCISE | Axogen, Inc. | 11,904 | 0.00 USD | |
| 01 Sept 2024 | EXERCISE | Axogen, Inc. | 11,904 | 0.00 USD | deriv |
| 18 Jun 2024 | GRANT_AWARD | Verastem, Inc. | 8,333 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Verastem, Inc. | 12,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 May 2014.